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http://arthritis-research.com/content/16/1/R11RESEARCH ARTICLE Open AccessDisrupting the Indian hedgehog signaling
pathway in vivo attenuates surgically induced
osteoarthritis progression in Col2a1-CreERT2;
Ihhfl/fl mice
Jingming Zhou1, Qian Chen1, Beate Lanske2, Braden C Fleming1, Richard Terek1, Xiaochun Wei3, Ge Zhang4,
Shaowei Wang1,3, Kai Li1,3 and Lei Wei1,3*Abstract
Introduction: Previous observations implicate Indian hedgehog (Ihh) signaling in osteoarthritis (OA) development
because it regulates chondrocyte hypertrophy and matrix metallopeptidase 13 (MMP-13) expression. However,
there is no direct genetic evidence for the role of Ihh in OA, because mice with cartilage or other tissue-specific
deletion of the Ihh gene die shortly after birth. We evaluated the role of Ihh in vivo via a Cre-loxP-mediated
approach to circumvent the early death caused by Ihh deficiency.
Methods: To evaluate the role of Ihh in OA development, Ihh was specifically deleted in murine cartilage using an Ihh
conditional deletion construct (Col2a1-CreERT2; Ihhfl/fl). The extent of cartilage degradation and OA progression after Ihh
deletion was assessed by histological analysis, immunohistochemistry, real-time PCR and in vivo fluorescence molecular
tomography (FMT) 2 months after OA was induced by partial medial meniscectomy. The effect of Ihh signaling on
cartilage was compared between Ihh-deleted mice and their control littermates.
Results: Only mild OA changes were observed in Ihh-deleted mice, while control mice displayed significantly more
cartilage damage. Typical OA markers such as type X collagen and MMP-13 were decreased in Ihh-deleted mice. In vivo
FMT demonstrated decreased cathepsins and MMP activity in knee joints of animals with deletion of Ihh.
Conclusions: These findings support the protective role of Ihh deletion in surgically induced OA. Thus, our findings
suggest the potential to develop new therapeutic strategies that can prevent and treat OA by inhibiting Ihh signaling
in chondrocytes.Introduction
Osteoarthritis (OA) is an extremely common disease
that is characterized by progressive degeneration of ar-
ticular cartilage and causes chronic joint pain and dis-
ability [1]. It has been reported that aging, trauma,
excessive mechanical load and genetic defects are associ-
ated with OA development [2-4], but the exact signaling
pathways involved in cartilage degeneration remain un-
clear. Recent evidence suggests that a bioactive protein,* Correspondence: Lei_Wei@brown.edu
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reproduction in any medium, provided the orIndian hedgehog (Ihh), may be involved because bloc-
king hedgehog (Hh) signaling with an inhibitor attenu-
ated OA progression [5]. In mammals, the Hh family
consists of three homologues: Ihh, Sonic hedgehog and
Desert hedgehog, which all share the same signaling
pathway. Ihh is a key signaling molecule and is synthe-
sized and expressed primarily in prehypertrophic chon-
drocytes during growth plate development. The main
function of Ihh is to regulate chondrocyte hypertrophy
and thereby endochondral ossification [6-8]. It has been
reported that some of the differentiation processes that
occur during embryogenesis are also present in OA chon-
drocytes [9-13]. During endochondral ossification, carti-
lage degradation is induced by matrix metallopeptidasestd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cytes. Similar to this process, cartilage degradation in OA
is mediated by MMPs [14-16]. Our interest in the present
study was to evaluate the role of Ihh in OA development
by specifically knocking down Ihh in chondrocytes to
obtain more direct evidence that Ihh signaling is critical to
OA progression.
Genetic studies using knockout mice have demonstrated
that activation of Ihh downstream signaling pathways
correlates with loss of articular cartilage thickness and
proteoglycan (PG) content [7]. Consistent with these ob-
servations, increased Hh signaling is involved in mouse
OA development [5] and increased type X collagen ex-
pression has been found in human knee joint cartilage
with early, focal, OA-like lesions [11,17]. However, these
studies did not exclude the possibility that other Hh mem-
bers are also involved OA cartilage degeneration, nor did
they establish which cells are involved in Hh signaling.
Our previous study in which human OA tissues were ana-
lyzed for Ihh and hypertrophic marker contents, as well as
the effect of Ihh signaling on OA chondrocyte hyper-
trophy, provided strong evidence that Ihh signaling may
promote OA development by driving chondrocyte hyper-
trophy [18].
The role of the Hh pathway in postnatal skeletal
homeostasis, however, is still unclear. Ohba et al. [19]
and Mak et al. [20] reported conflicting findings. They
used genetic mouse models to delete Patched, the
membrane-bound downstream receptor of Hh that acts
as a functional inhibitor of Hh signaling, to address the
role of the enhanced Hh signaling in postnatal bone
cells. Ohba et al. demonstrated that enhanced Hh signa-
ling increased bone mass, whereas Mak et al. showed
that enhanced Hh signaling resulted in decreased bone
mass. Furthermore, similar observations have also been
found in chondrocytes. Ihh inhibits chondrocyte hyper-
trophy indirectly by regulating parathyroid hormone–
related protein (PTHrP) expression [21], but Ihh sig-
naling can also directly promote chondrocyte hyper-
trophy in the absence of PTHrP [22]. The direct and
indirect effects of Ihh signaling oppose each other. These
context-dependent effects indicate that the mediation of
cartilage changes in OA may be a complex network
involving multiple factors. Therefore, it is important to
obtain direct genetic evidence to demonstrate the role of
Ihh in OA. Conventional Ihh-knockout mice are em-
bryonic lethal, and even mice with cartilage-specific
deletion of the Ihh gene (targeted by Col2a1-Cre) die
shortly after birth [23]. To explore the role of Ihh in
OA, we used a cartilage-specific, inducible loss of func-
tion approach. We used an OA model utilizing Ihh
conditional knockout mice (Col2a1-CreERT2; Ihhfl/fl), a
tamoxifen (TM)-inducible CreERT2 recombinase and par-
tial medial meniscectomy (PMM) [24,25]. This murinemodel allowed us to test the hypothesis that inhibition of
Ihh signaling decreases cartilage degeneration. A unique
element of this assessment is the use of fluorescence mo-
lecular tomography (FMT) to monitor cathepsin and
MMP activity in knee joints. Furthermore, we tested the
effect of blocking Ihh in human cartilage explants to
determine if the mouse results could be generalized to
human tissue. The clinical implication of our study is that
targeting Ihh signaling may be a viable strategy to prevent
or treat OA.
Methods
Animals
Col2a1-CreERT2; Ihhfl/fl mice (supplied by BL) were bred as
previously described [6]. Two-month-old male Col2a1-
CreERT2; Ihhfl/fl mice (N = 60) were divided into two groups:
TM (n = 30) and no TM (n = 30). Each group was subdi-
vided into three subgroups: PMM (n = 12), sham (n = 10)
and no surgery (n = 8). In the TM group, 2-month-old
mice were injected with TM (1 mg/10 g/day for 5 con-
secutive days) to delete Ihh. In the no TM group mice,
were injected with five doses of solvent (corn oil) as a con-
trol. The animals were randomized to undergo PMM sur-
gery (the PMM group), sham surgery (the sham group) or
no treatment (the no surgery group) at 3 months of age.
They were killed at 5 months of age. Right hindlimbs were
harvested immediately after the mice were killed. Ap-
proval of the animal experiments was obtained from the
Institutional Animal Care and Use Committee at Rhode
Island Hospital.
Surgery
To induce posttraumatic OA in the PMM subgroups,
the right anterior medial menisci were removed using a
surgical microscope and a microsurgical technique as
previously described [26]. After irrigating the surgical
site with saline to remove tissue debris, the joint capsule
and skin incision were closed in layers. During the pro-
cedure, close attention was paid not to injure the articu-
lar cartilage. The right hind knee joints of mice in the
sham subgroups were sham-operated using the same
approach, but without meniscectomy. Postoperatively,
animals were allowed unrestricted activity and free ac-
cess to food and water.
Fluorescence molecular tomography
Inflammation-associated factors were monitored by FMT
in vivo after 2 months. FMT enables real-time three-
dimensional quantitation of fluorochrome distribution in
tissues of live animals [27-30]. The mice were injected
with a single dose of ProSense 750 EX and MMPSense
680 fluorescent imaging agents (PerkinElmer, Waltham,
MA, USA) 24 hours before imaging. ProSense detects
cathepsins B, L, and S and plasmin. MMPSense detects
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were anesthetized with an intraperitoneal injection of
ketamine (75 mg/kg) and medetomidine (1 mg/kg), placed
in an upright position in the imaging chamber and then
imaged using the VisEn FMT Optical Imaging System
(PerkinElmer). A near-infrared laser diode emitting
continuous wave radiation at wavelengths of 670 nm or
746 nm transilluminated the lower body of each animal
from posterior to anterior, and both excitation and emis-
sion signals were detected by a charge-coupled device
camera and appropriate band-pass filters. The no TM-
PMM group (n = 12), TM-PMM group (n = 8) and TM-
sham group (n = 3) were imaged. The picomolar concen-
trations of probes in the knee joint were determined using
region of interest analysis. We used FMT imaging to con-
firm that Ihh deletion decreases inflammatory mediators
in vivo, then compared the results with histological scores
and molecular studies.
Histology
After the mice were killed with carbon dioxide, the knee
joints of right hindlimbs were harvested and immersed
in 10% formalin for 72 hours. The specimens were dec-
alcified in 20% ethylenediaminetetraacetic acid solution
(pH 7.2). They were processed in a Tissue-Tek VIP 1000
tissue processor (Miles Laboratories, Elkhart, IN, USA)
and embedded in a single block of Paraplast X-TRA
medium (Sigma-Aldrich, St Louis, MO, USA). Blocks
were trimmed to expose tissue using a rotary microtome
(Reichert-Jung, Vienna, Austria), and 6-μm coronal sec-
tions were mounted on slides. Safranin O staining was per-
formed, and the severity of cartilage damage was assessed
using the Osteoarthritis Research Society International
Osteoarthritis Cartilage Histopathology Assessment Sys-
tem (OOCHAS) (OA score = grade × stage; range, 0 to 24)
[31]. Three independent blinded observers (LW, HL and
JZ) scored each section, and the scores for the medial and
lateral tibial condyles were averaged within each joint.
Immunohistochemistry
To detect the distribution of Ihh, MMP-13 and types II
and X collagens in cartilage, 6-μm sections were col-
lected on positively charged glass slides (Thermo Fisher
Scientific, Asheville, NC, USA). The sections were dried
on a hotplate to increase adherence to the slides. Im-
munohistochemistry was carried out using the 3,3′-
diaminobenzidine (DAB) streptavidin-peroxidase (SP)
DAB Histostain-SP immunohistochemistry kit (ZYMED
Laboratories/Invitrogen, Carlsbad, CA, USA). Sections
were deparaffinized and rehydrated using conventional
methods. Endogenous peroxidase was blocked by trea-
ting the sections with 3% hydrogen peroxide in me-
thanol (Sigma-Aldrich) for 30 minutes. The sections
were digested by 5 mg/ml hyaluronidase in phosphate-buffered saline (PBS) (Sigma-Aldrich) for 20 minutes.
The sections were incubated with specific antibodies
against Ihh (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), MMP-13 (Santa Cruz Biotechnology), types II and
X collagens (Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, IA, USA) and type II colla-
gen breakdown product (IBEX Technologies, Mont-Royal,
QC, Canada), respectively, at 4°C overnight. The negative
control sections were incubated with isotype-matched
control serum (2 μg/ml) (R&D Systems, Minneapolis,
MN, USA) in PBS. Thereafter the sections were treated
sequentially with biotinylated secondary antibody and SP
conjugate (ZYMED Laboratories/Invitrogen), then de-
veloped in DAB chromogen (ZYMED Laboratories/
Invitrogen). The sections were counterstained with hema-
toxylin (ZYMED Laboratories/Invitrogen). Photomicro-
graphs were taken with a Nikon E800 microscope (Nikon,
Melville, NY, USA) [32].
Laser capture and real-time PCR
To quantify the mRNA levels of Ihh, Gli1, types II and X
collagens, MMP-13, Runx2 and aggrecan, a formalin-fixed,
paraffin-embedded Paradise PLUS Reagent System (MDS
Analytical Technologeis/Molecular Devices, CA, USA) was
used to extract and amplify RNA from articular cartilage
[33]. Tissue sections (10 μm) were air-dried and dehy-
drated through graded alcohols and subjected to laser-
captured microdissection (LCM) within 2 hours of depar-
affinization as previously described [34]. Approximately
2,000 cells were present in microdissected articular cartil-
age. The articular cartilage was captured on LCM Macro
CapSure Caps (Applied Biosystems) using the Arcturus
AutoPix Automated Laser Capture Microdissection Sys-
tem (Applied Biosystems). The quantification of mRNA
was performed by real-time PCR using the QuantiTect
SYBR Green PCR kit (QIAGEN, Valencia, CA, USA) with
the CFX384 Real-Time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA, USA). Each reaction was per-
formed in triplicate. The following primers were used:
mouse Ihh: forward, 5′-CCA CTT CCG GGC CAC ATT
TG-3′, and reverse, 5′-GGC CAC CAC ATC CTC CAC
CA-3′; mouse Gli1: forward, 5′-GGT CCG GAT GCC
CAC GTG AC-3′, and reverse, 5′-TCC CGC TTG GGC
TCC ACT GT-3′; mouse Gli2: forward, 5′-TGG CAG
CGA TGG GCC TAC CT-3′, and reverse, 5′-GCC GTG
TGC TGC TGT TTG GC-3′; mouse type X collagen: for-
ward, 5′-GCC AGG AAA GCT GCC CCA CG-3′, and re-
verse, 5′-GAG GTC CGG TTG GGC CTG GT-3′; mouse
MMP-13: forward, 5′-GGA CCT TCT GGT CTT CTG
GC-3′, and reverse, 5′-GGA TGC TTA GGG TTG GGG
TC-3′; mouse Runx2: forward, 5′-CCG CAC GCA AAC
CGC ACC AT-3′, and reverse, 5′-CGC TCC GGC CCA
CAA ATC TC-3′; and mouse aggrecan: forward, 5′-CAG
TGG GAT GCA GGC TGG CT-3′, and reverse, 5′-CCT
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tions were as follows: 2-minute preincubation at 50°C; 10
minutes at 95°C for enzyme activation; and 40 cycles at 95°C
denaturation for 10 seconds, 55°C annealing for 30 seconds
and 72°C extension for 30 seconds. The comparative thresh-
old cycle (Ct) method, that is, the 2−ΔΔCt method, was used
to calculate fold amplification [34].
Human articular cartilage organ culture and real-time PCR
Human OA cartilage samples were obtained during knee
replacement surgery. This part of the study was also ap-
proved by the Institutional Review Board at Rhode Island
Hospital, and informed consent was obtained from each
donor. The samples were cut into 4-mm3 pieces, cultured
in Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum and treated with the Hh inhibitor
cyclopamine (20 μM) or dimethyl sulfoxide (DMSO) as
the control. Total RNA was isolated after 48 hours of
treatment. The quantification of mRNA was performed by
real-time PCR using the QuantiTect SYBR Green PCR kit
with the CFX384 Real-Time PCR Detection System as de-
scribed above. The following primers were used: human
Gli1: forward, 5′- GAA CCC TTG GAA GGT GAT ATG
TC-3′, and reverse, 5′-GGC AGT CAG TTT CAT ACA
CAG AT-3′; human type X collagen: forward, 5′-TGC
CTC TTG TCA GTG CTA ACC-3′, and reverse, 5′-GCG
TGC CGT TCT TAT ACA GG-3′; and human MMP-13:
forward, 5′-TGC TGC ATT CTC CTT CAG GA-3′, and
reverse, 5′- ATG CAT CCA GGG GTC CTG GC-3′.
Gene expression levels were calculated as described
above.
Statistical analysis
Data are expressed as means ± SD. Two-tailed paired
t-tests were used to compare mRNA levels between the
no TM-PMM and TM-PMM groups, and between the
cyclopamine and DMSO groups. MMPSense and Pro-
Sense signals between the no TM-PMM and TM-PMM
groups were also compared using two-tailed, paired t-
tests. A probability level less than 5% was considered
significant. The OOCHAS score in different groups were
analyzed by one-way analysis of variance with multiple
pair-wise comparisons made by the Student-Newman-
Keuls method (three comparisons or more) at a rejection
level of 5% unless otherwise noted.
Results
Validation of animal model
Several research groups have used the Col2a1-CreERT2;
Ihhfl/fl-transgenic mouse model, which they validated in
their published papers [35-37]. In our present study,
PCR was used for genotyping to confirm disruption of
both Ihh alleles and the presence of Cre (Figure 1A).
Before TM induction, homozygous transgenic and wild-type mice showed no difference in phenotypes, that is,
similar body size, normal PG staining and open growth
plates, at 2 months of age (Figure 1B). One month after
TM injection, PMM surgery was performed on the right
knees. Radiographic analysis was used to confirm that
right medial menisci had been removed successfully
(Figure 2A). Our real-time PCR results showed knock-
down of Ihh expression in cartilage 3 months after TM
injection (Figure 2B). Closure of the growth plate was also
consistently evidenced after TM was injected (see details
in Additional file 1). These observations are in accord with
previous findings in which Cre-recombinase-mediated
deletion of a floxed gene expressed in articular chondro-
cytes at the adult stage can be highly specific and retain
high efficiency several months after induction [38,39].
Deletion of Ihh has chondroprotective effects
Mice in the no TM-PMM group had more signaling de-
tected by ProSense and MMPSense fluorescent imaging
agent in the surgical knee compared to the TM-sham
group, indicating that PMM surgery elevated protease
activity in the knee joint (Figure 3). Deletion of Ihh
reduced the ProSense signal in the TM-PMM mice
by 89.0% compared to control mice (no TM-PMM)
(P = 0.016) (Figure 3A). MMPSense signal in the TM-
PMM group was decreased by 71.9% compared to the
no TM-PMM group (P = 0.042) (Figure 3B). Overall, the
FMT results show that deletion of Ihh leads to de-
creased production of proteases after surgery, which is
in accordance with less severe OA damage in the TM-
PMM mice (Figure 4).
Histological analysis demonstrated that the articular
cartilage surface of the knee joint in the TM-PMM
group was Safranin O–positive with a relatively intact
cartilage surface. In contrast, the no TM-PMM group, in
which Ihh was present, exhibited severe cartilage da-
mage and loss of PG staining (Figure 4A). We also quan-
tified the extent of OA damage using the OOCHAS
score. The entire tibial cartilage surface of each sample
was scored by three independent reviewers. In the no
TM-PMM group, cartilage displayed more severe OA
damage than the TM-PMM group, in which Ihh was
knocked down (Figure 4B). Consistent with the Safranin
O staining results, the OOCHAS scores of the sham
groups and the no-surgery groups were close to zero,
indicating minimal OA damage (Figure 4B). The TM-no
Surgery and no TM–no Surgery groups showed no
change in OOCHAS scores (Figures 4A and 4B), which
excluded the possibility that TM had an effect on cartil-
age. We also compared the TM-sham and no TM–sham
groups. As expected, the sham operation did not induce
OA damage in cartilage (Figures 4A and 4B). The TM-
sham group was used as the control group in the next
experiments.
Figure 1 Col2a1-CreERT2; Ihhfl/fl mice exhibit normal phenotype before induction. (A) Insertion of loxP restriction enzyme site in the Indian
hedgehog (Ihh) allele was confirmed by PCR. Lane 1: heterozygous Ihhfl/fl (382 bp and 484 bp), lane 2: homozygous Ihhfl/fl (382 bp), lane 3: wild
type (WT) (484 bp), lane 4: 50-bp DNA marker and lane 5: Cre-recombinase (328 bp). (B) X-rays and Safranin O–stained images show normal
growth plate and proteoglycan staining in WT mice (a) and mutant mice (b) at 2 months of age without deletion of Ihh.
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the expression of MMPs and type X collagen. In the
TM-PMM and TM-sham groups, Ihh expression in
chondrocytes was less than in the no TM–PMM group
(Figure 5A). MMP-13 and type X collagen were elevated
in cartilage of the no TM–PMM group compared to Ihh-
deleted cartilage (the TM-PMM and TM-sham groups), in
which less OA damage was observed (Figures 5B and 5C).
In contrast, type II collagen content was higher in car-
tilage in the TM-PMM and TM-sham groups than in the
no TM–PMM group (Figure 5D), and type II collagen
degradation was inhibited in the TM groups compared to
the no TM–PMM group (Figure 5E).
Consistent with the immunohistochemical data (Figure 5),
real-time PCR revealed a significant decrease in Ihh
expression in Ihh-deleted mice (TM) compared to control
mice (no TM). Similarly, in the Ihh-deleted mice, the
expression of Gli1, Gli2, type X collagen, MMP-13 andFigure 2 Validation of Indian hedgehog deletion and partial medial m
meniscus of the left knee joint without partial medial meniscectomy (PMM
meniscus of the right knee joint (indicated by arrow in right panel). (B) Res
hedgehog (Ihh) is decreased by 46.5% in tamoxifen (TM)-injected mice. DaRunx2 were decreased and aggrecan and type II collagen
were increased (Figure 6A). Human cartilage organ cul-
ture also showed decreased Gli1, type X collagen and
MMP-13 after treatment with the Hh inhibitor cyclopa-
mine (Figure 6B).
Discussion
The results of our study demonstrate that Ihh signaling
is part of the pathobiology of OA development. Previous
studies have demonstrated that Ihh plays an important
role during growth plate and bone development by regu-
lating type X collagen, MMP-13 and Runx2 expression
[5,10,40-43]. In our previous study, we reported elevated
levels of Ihh in human OA cartilage and synovial fluid
compared to normal control samples [18]. Moreover, we
earlier found that upregulation of Ihh promoted the
hypertrophic phenotype and induced typical hypertro-
phic markers such as type X collagen and MMP-13 [18].eniscectomy. (A) Radiographs using soft-tissue settings show medial
) surgery (indicated by arrowhead in left panel) and absence of medial
ults of real-time PCR are shown. Relative fold expression of Indian
ta are means ± SD. TM, n = 6. no TM, n = 8. *P < 0.005.
Figure 3 Cathepsin and matrix metalloprotease activity were decreased in Indian hedgehog–deleted mice 2 months after partial
medial meniscectomy. Representative images produced with ProSense (A) and MMPSense (B) fluorescent imaging agents (top panels) and
summary results (bottom panels) are shown. Data are means ± SD. No tamoxifen–partial medial meniscectomy (TM-PMM), n = 12; TM-PMM, n = 8;
and TM-sham, n = 3. *P = 0.016, #P = 0.042.
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OA development by inducing chondrocyte hypertrophy
and the expression of genes known to cause cartilage
degeneration, confirming previous observations made by
others [10,40,41,44]. Our findings are in agreement with
those of Lin et al., who reported that human cartilage
explants treated with Hh blocking agents exhibited
decreased expression of type X collagen and MMP-13,
but that Ihh ligand stimulation induced the expression
of these two genes [5]. Thus, it is likely that induction ofFigure 4 Deletion of Indian hedgehog alleviates osteoarthritis cartilag
Safranin O staining. PMM, partial medial meniscectomy; TM, tamoxifen. (B)
Histopathology Assessment System (OOCHAS) scores are shown. Data are m
*P < 0.0001. In the control groups (No TM-Sham, n = 10; TM-Sham, n = 10; No
differences, #P = 0.585.type X collagen and MMP-13 may be caused by in-
creased Ihh signaling in OA cartilage in vivo. However,
these previous studies were unable to exclude the pos-
sibility that other Hh family members are also involved
OA cartilage degeneration or to determine whether Ihh
signaling is associated with OA development, a secon-
dary pathway or an attempt at healing damaged OA car-
tilage by reactivating developmental pathways.
In this study, we used, for the first time to the best of
our knowledge, genetically deleted Ihh mice to directlye damage. (A) Coronal sections of mouse knee joints are shown after
Osteoarthritis Research Society International Osteoarthritis Cartilage
eans ± SD. No TM-PMM, n = 12; TM-PMM, n = 12; TM-Sham, n = 10.
TM-No Surgery, n = 8; TM-No Surgery, n = 8), there were no significant
Figure 5 Indian hedgehog, matrix metalloprotease 13 and type X collagen expression is reduced in Ihh-deleted mice, but type II collagen
and aggrecan are preserved. Immunohistochemical staining was used in osteoarthritis (OA)-induced tibial articular cartilage of 5-month-old mice
for Indian hedgehog (Ihh) (A), matrix metalloprotease 13 (MMP-13) (B), type X collagen (Col X) (C), type II collagen (Col II) (D) and type II collagen
breakdown products (Degraded Col II) (E). PMM, partial medial meniscectomy; TM, tamoxifen. Positive signals (brown staining) are indicated by
arrows. Inside the black box was image taken under the 20x objective lens, and from which a small area was further enlarged under 20x objective
lens (inside the red box)
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neration. Our results provide solid evidence that the de-
letion of Ihh prevents cartilage damage at the tissue level
(Figures 4A and B). Gli2 and Gli3 are major signaling
molecules in the Ihh pathway that promote osteoblast
formation by regulating Runx2 [42]. As a direct down-
stream target of the Ihh pathway, Gli1 is regulated by
Gli2 and Gli3 [45]. We also found that at the cellular
and molecular levels, Gli1 and Gli2, type X collagen (the
typical hypertrophic chondrocyte marker) and other
cartilage-degrading enzymes, such as MMPs and ca-
thepsins are effectively downregulated by Ihh deletion
(Figures 3, 5 and 6A). In contrast, increased cartilage
matrix molecules type II collagen and aggrecan were
present in Ihh-deleted mice (Figures 5 and 6A). We fur-
ther demonstrated that Ihh blockade by cyclopamine
inhibits the expression of type X and MMP-13 in human
cartilage organ cultures. Increased MMP-13 activity
leads to structural damage in murine OA cartilage, and
knockdown of MMP-13 decreases cartilage damage in
OA [41]. Thus, our finding that deletion or inhibition of
Ihh by genetic and pharmacological approaches down-
regulates MMP-13 expression and activity suggests that
chondroprotection in patients with early-stage disease
may be possible by inhibiting this pathway.
We have also demonstrated that FMT is highly con-
sistent with the molecular and immunohistochemical
results in our OA model (Figure 3). Therefore, FMTprovides a new means by which to assess the effects of
OA treatments on inflammation and cartilage degra-
dation in the murine model in vivo. This noninvasive
technique has been used for research in oncology as well
as in inflammatory, pulmonary, cardiovascular and ske-
letal diseases [27-30]. The advantages of this technology
are its capability to longitudinally monitor and quantify
biological targets in vivo over multiple time points and
to better understand the mechanism and progression of
disease. Furthermore, FMT can be used to support data
derived from other cellular and molecular in vitro assays.
Peterson et al. compared FMT with traditional methods
in evaluating rheumatoid arthritis. Their study showed
that FMT provides more sensitive readouts in the
pathology of the disease and that it is possible to use
FMT results to predict disease development [30]. In our
present study, we found that the findings obtained using
the ProSense and MMPSense fluorescent imaging agents
were consistent with our histological results. The value
of FMT to study OA onset and progression is encour-
aging but still requires validation in future longitudinal
studies.
Recent studies have demonstrated that Ihh expression
is very low in healthy human articular cartilage but in-
creases during OA development and that increased Ihh
expression is associated with the severity of OA cartilage
damage [18]. Furthermore, the increase of Ihh has been
also reported in early-stage human articular cartilage
Figure 6 Decreased Indian hedgehog signaling inhibits Ihh downstream targets in osteoarthritis cartilage. (A) Indian hedgehog (Ihh)
deletion leads to downregulation of Ihh downstream targets in osteoarthritis (OA) cartilage 2 months after partial medial meniscectomy. (a) Laser-captured
microdissection was used to analyze gene expression in articular cartilage. Articular cartilage (highlighted in red) before and after microdissection is
shown. (b) Results of real-time PCR are shown. The expression of Ihh, Gli1, Gli2, matrix metalloprotease (MMP-13), type X collagen (Col X) and Runx2
was significantly decreased, and the expression of aggrecan and type II collagen (Col II) was increased, respectively, in the Ihh-deleted mice (tamoxifen
(TM)) (n = 6) compared to the control animals (no TM) (n = 8). Data are means ± SD. *P < 0.00001, #P < 0.0005, +P < 0.001, ^P < 0.05. (B) Cyclopamine
decreased expression of Gli1, MMP-13 and type X collagen in human OA cartilage. Relative mRNA levels in human cartilage organ cultures 48 hours
after treatment with cyclopamine (n = 8) and dimethyl sulfoxide (DMSO) controls (n = 8) are shown. Data are means ± SD (n = 8). *#^P < 0.0001.
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observed 2 months after surgery, which is enough time
for OA to develop to a stage at which Ihh-deleted and
nondeleted groups can be differentiated. Therefore, we
did not evaluate shorter and longer time periods. How-
ever, previous reports on human OA cartilage tissues
have suggested that the increase of Ihh may play a role
in the initiation of OA [17,18].
Our findings suggest the therapeutic potential of tar-
geting Ihh to prevent and treat OA cartilage degeneration.However, it is not possible to delete Ihh in larger animals,
and Ihh gene deletion is not an option for OA treatment
in humans. Chemical inhibitors of Hh signaling cause
severe side effects, including holoprosencephaly, cleft lip
and palate and limb defects [46-50]. Therefore, efficient
knockdown of Ihh achieved by local delivery of small
interfering RNA (siRNA) might be a more effective
strategy. Recent studies have demonstrated that both lipo-
some particles and nanoparticles can be used for local
siRNA delivery to musculoskeletal tissues [51,52]. These
Zhou et al. Arthritis Research & Therapy 2014, 16:R11 Page 9 of 10
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Ihh knockdown in future studies utilizing large animal
OA models.
Conclusions
This study provides direct evidence that knockout of Ihh
prevents the development of OA and that FMT can be
used to evaluate cartilage health in vivo in the murine
model. This chondroprotective effect results from inhi-
biting chondrocyte hypertrophy and the expression of
genes known to cause cartilage degradation. Moreover,
our results give further support to the concept of Ihh in-
hibition as a therapeutic strategy to prevent and treat OA.
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